Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Acellular Dermal Matrix Implant For Breast Reconstruction

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06139588Completed

Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based Reconstruction

NCT03737500Not ApplicableCompleted

Standard Silicone-based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast Cancer

Showing all 2 trials

Research Network

Common Treatments

  • Acellular Dermal Matrix Implant For Breast Reconstruction1
  • Blite Light Weight Breast Implant1
  • Standard Siliconebased Breast Implant1

Active Sponsors

  • European Institute of Oncology1
  • Istituti Clinici Scientifici Maugeri SpA1

Top Investigators

Related Conditions

  • Breast Cancer2
  • Breast Implant Complications2
  • Implant Capsular Contracture1
  • Radiotherapy Side Effect1
  • Breast Seroma1

Activity Timeline